心脏再同步化治疗患者极长期生存与晚期心脏性猝死
这项欧洲多中心观察性队列研究纳入1775例CRT植入后存活5年的缺血性或非缺血性扩张型心肌病患者,评估极长期结局。在额外平均30个月随访中,全因死亡调整HR为0.99(95%CI 0.79-1.22),晚期SCD仅占全部死亡的6.1%,两组无显著差异;进展性心衰仍为主要死因。
要点
- CRT后存活5年患者中,进展性心衰仍是主要死因,占CRT-P 42.8%、CRT-D 52.6%。
- 晚期SCD占全部死亡的6.1%,CRT-P与CRT-D组年发生率无显著差异(调整HR 1.0)。
- CRT-D与CRT-P全因死亡调整HR 0.99(95%CI 0.79-1.22),未见显著获益。
核心结论
- CRT植入后存活5年的患者中,进展性心衰死亡仍是最常见死因,晚期SCD占比较低且与是否植入除颤器无关。
研究设计与样本
- 欧洲多中心观察性队列研究,纳入1775例CRT植入后存活5年的缺血性或非缺血性扩张型心肌病患者。
主要发现
- 额外平均随访30个月(IQR 10-42)期间共观察到473例死亡。
- CRT-D与CRT-P年年龄标化死亡率分别为40.4(95%CI 35.3-45.5)和97.2(95%CI 85.5-109.9)/1000患者年。
- 全因死亡调整HR为0.99(95%CI 0.79-1.22)。
- CRT-P与CRT-D年SCD发生率分别为8.5和5.8/1000患者年,调整HR 1.0(95%CI 0.45-2.44)。
临床怎么用
- CRT后存活5年以上的患者,应重点关注心衰进展的预防与管理,而非单纯依赖除颤器预防晚期SCD。
局限性
- 为观察性队列研究,可能存在残留混杂。
- 仅纳入存活5年的患者,存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The very long-term outcome of patients who survive the first few years after receiving cardiac resynchronization therapy (CRT) has not been well described thus far. We aimed to provide long-term outcomes, especially with regard to the occurrence of sudden cardiac death (SCD), in CRT patients without (CRT-P) and with defibrillator (CRT-D). METHODS AND RESULTS: A total of 1775 patients, with ischaemic or non-ischaemic dilated cardiomyopathy, who were alive 5 years after CRT implantation, were enrolled in this multicentre European observational cohort study. Overall long-term mortality rates and specific causes of death were assessed, with a focus on late SCD. Over a mean follow-up of 30 months (interquartile range 10-42 months) beyond the first 5 years, we observed 473 deaths. The annual age-standardized mortality rates of CRT-D and CRT-P patients were 40.4 [95% confidence interval (CI) 35.3-45.5] and 97.2 (95% CI 85.5-109.9) per 1000 patient-years, respectively. The adjusted hazard ratio (HR) for all-cause mortality was 0.99 (95% CI 0.79-1.22). Twenty-nine patients in total died of late SCD (14 with CRT-P, 15 with CRT-D), corresponding to 6.1% of all causes of death in both device groups. Specific annual SCD rates were 8.5 and 5.8 per 1000 patient-years in CRT-P and CRT-D patients, respectively, with no significant difference between groups (adjusted HR 1.0, 95% CI 0.45-2.44). Death due to progressive heart failure represented the principal cause of death (42.8% in CRT-P patients and 52.6% among CRT-D recipients), whereas approximately one-third of deaths in both device groups were due to non-cardiovascular death. CONCLUSION: In this first description of very long-term outcomes among CRT recipients, progressive heart failure death still represented the most frequent cause of death in patients surviving the first 5 years after CRT implant. In contrast, SCD represents a very low proportion of late mortality irrespective of the presence of a defibrillator.
引用
- Barra S, Duehmke R, Providência R, et al. Very long-term survival and late sudden cardiac death in cardiac resynchronization therapy patients. Eur Heart J. 2019. PMID: 31046090. doi:10.1093/eurheartj/ehz238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。